Correction to: Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center

被引：0
|
作者：
Yosuke Kano
Manabu Ohashi
Naoki Hiki
Daisuke Takahari
Keisho Chin
Kensei Yamaguchi
Yasuo Tsuda
Yoshiaki Shoji
Itaru Yasufuku
Kojiro Eto
Satoshi Ida
Koshi Kumagai
Souya Nunobe
Takeshi Sano
机构：
[1] Japanese Foundation for Cancer Research,Department of Gastroenterological Surgery, Gastroenterological Center, Cancer Institute Hospital
[2] Japanese Foundation for Cancer Research,Department of Gastroenterological Medicine, Gastroenterological Center, Cancer Institute Hospital
来源：
Gastric Cancer | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the original publication of this article, the 5-year OS rates of the S-1 group in the ACTS-GC according to TNM-6 were described incorrectly in Table 4. The revised Table 4 is given in this correction.
引用
收藏
页码：1072 / 1072
相关论文
共 50 条
  • [1] Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center
    Yosuke Kano
    Manabu Ohashi
    Naoki Hiki
    Daisuke Takahari
    Keisho Chin
    Kensei Yamaguchi
    Yasuo Tsuda
    Yoshiaki Shoji
    Itaru Yasufuku
    Kojiro Eto
    Satoshi Ida
    Koshi Kumagai
    Souya Nunobe
    Takeshi Sano
    Gastric Cancer, 2018, 21 : 1024 - 1030
  • [2] Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center (vol 21, pg 1024, 2018)
    Kano, Yosuke
    Ohashi, Manabu
    Hiki, Naoki
    Takahari, Daisuke
    Chin, Keisho
    Yamaguchi, Kensei
    Tsuda, Yasuo
    Shoji, Yoshiaki
    Yasufuku, Itaru
    Eto, Kojiro
    Ida, Satoshi
    Kumagai, Koshi
    Nunobe, Souya
    Sano, Takeshi
    GASTRIC CANCER, 2018, 21 (06) : 1072 - 1072
  • [3] Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists
    Kano, Yosuke
    Ohashi, Manabu
    Hiki, Naoki
    Takahari, Daisuke
    Chin, Keisho
    Yamaguchi, Kensei
    Ida, Satoshi
    Kumagai, Koshi
    Sano, Takeshi
    Nunobe, Souya
    SURGERY TODAY, 2020, 50 (10) : 1197 - 1205
  • [4] Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists
    Yosuke Kano
    Manabu Ohashi
    Naoki Hiki
    Daisuke Takahari
    Keisho Chin
    Kensei Yamaguchi
    Satoshi Ida
    Koshi Kumagai
    Takeshi Sano
    Souya Nunobe
    Surgery Today, 2020, 50 : 1197 - 1205
  • [5] Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer
    Kasahara, Kohei
    Kunisaki, Chikara
    Sato, Sho
    Kondo, Hiroki
    Takahashi, Masazumi
    Tamura, Yuko
    Tsuchiya, Nobuhiro
    Tanaka, Yusaku
    Sato, Kei
    Kimura, Jun
    Kosaka, Takashi
    Ono, Hidetaka
    Makino, Hirochika
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2023, 43 (06) : 2841 - 2850
  • [6] Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy
    Hosokawa, Ayumu
    Sugiyama, Toshiro
    Ohtsu, Atsushi
    Doi, Toshihiko
    Hattori, Santa
    Kojima, Takashi
    Yano, Tomonori
    Minashi, Keiko
    Muto, Manabu
    Yoshida, Shigeaki
    JOURNAL OF GASTROENTEROLOGY, 2007, 42 (07) : 533 - 538
  • [7] Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy
    Ayumu Hosokawa
    Toshiro Sugiyama
    Atsushi Ohtsu
    Toshihiko Doi
    Santa Hattori
    Takashi Kojima
    Tomonori Yano
    Keiko Minashi
    Manabu Muto
    Shigeaki Yoshida
    Journal of Gastroenterology, 2007, 42 : 533 - 538
  • [8] Alteration of recurrence patterns and prognostic factors by adjuvant S-1 monotherapy in patients with stage II/III gastric cancer
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Iwata, Naoki
    Yamada, Suguru
    Fujii, Tsutomu
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [9] Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study
    Choi, Seohee
    Min, Jae-Seok
    Jeong, Sang-Ho
    Yoo, Moon-Won
    Son, Young-Gil
    Oh, Sung Jin
    Kim, Jong-Han
    Park, Joong-Min
    Hur, Hoon
    Jee, Ye Seob
    Hwang, Sun-Hwi
    Jin, Sung-Ho
    Lee, Sang Eok
    Lee, Young-Joon
    Seo, Kyung Won
    Park, Sungsoo
    Lee, Chang Min
    Kim, Chang Hyun
    Jeong, In Ho
    Lee, Han Hong
    Choi, Sung Il
    Lee, Sang-Il
    Kim, Chan-Young
    Chae, Hyundong
    Son, Myoung-Won
    Pak, Kyung Ho
    Kim, Sungsoo
    Lee, Moon-Soo
    Kim, Hyoung-Il
    JOURNAL OF GASTRIC CANCER, 2022, 22 (01) : 67 - 77
  • [10] Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy
    Kano, Yosuke
    Ohashi, Manabu
    Muneoka, Yusuke
    Takahari, Daisuke
    Chin, Keisho
    Yamaguchi, Kensei
    Ida, Satoshi
    Kumagai, Koshi
    Makuuchi, Rie
    Sano, Takeshi
    Nunobe, Souya
    EJSO, 2021, 47 (12): : 3097 - 3104
12345